News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Meda AB (MEDA-A.ST) Release: Astepro Approved in Europe


3/20/2012 9:52:36 AM

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News:

Astepro (STO:MEDAA) has received registration approval in Europe via the decentralized procedure. Astepro is a new nasal spray for the treatment of allergic rhinitis. National registration processes, including price and reimbursement, will now follow in each country. Launch is expected next year.

Read at BioSpace.com

comments powered by Disqus
Meda AB
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES